Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hooman Kamel.
NEJM Journal Watch | 2016
Facep Jennifer L. Wiler; Hooman Kamel
Transient ischemic attacks (TIAs) can lead to subsequent stroke within 90 days in an estimated 10% to 20% of cases. Current guidelines recommend prompt testing for stroke risk factors including hypercholesterolemia, carotid stenosis, and atrial fibrillation. Using data from the Ontario Stroke Registry for 8540 adult patients with an emergency department (ED) diagnosis of TIA or minor stroke, researchers compared outcomes and adherence to recommended care between those admitted …
NEJM Journal Watch | 2016
Hooman Kamel
Numerous randomized trials have assessed thrombolytic therapy for the treatment of acute ischemic stroke. Pooled analyses from these trials indicate that alteplase treatment improves functional outcomes, but the effect on survival remains unclear. Investigators now report the results of long-term follow-up among a subset of participants in the Third International Stroke Trial (IST-3). Of the 3035 participants in IST-3, 1946 were enrolled in the …
NEJM Journal Watch | 2015
Hooman Kamel
Treatment of hypertension reduces the risk for intracerebral hemorrhage (ICH). However, we do not know the optimal blood pressure target for patients
NEJM Journal Watch | 2014
Hooman Kamel
Cerebral cavernomas consist of thin-walled vascular channels that can provoke seizures or cause neurological deficits from hemorrhage. Recent data indicate a 25% risk for rebleeding during the 5 years after an initial hemorrhage into a cavernoma. To reduce seizure frequency or prevent rebleeding, many cavernomas are surgically excised, but little data support this practice. Investigators have therefore examined outcomes after surgical excision of cavernomas …
NEJM Journal Watch | 2013
Hooman Kamel
Two research groups conducted randomized trials to assess the long-term effects of endovascular stroke treatment.Ciccone and colleagues randomized 362
NEJM Journal Watch | 2013
Hooman Kamel
One third of ischemic strokes remain cryptogenic even after thorough inpatient evaluation. Numerous studies suggest that some of these patients may have paroxysmal atrial fibrillation (AF) that remains undiagnosed during their stroke hospitalization. Failing to detect these cases of AF may result in suboptimal antithrombotic therapy. However, what type and duration of cardiac monitoring should be used to rule out subclinical AF remain unclear. To address this question, …
NEJM Journal Watch | 2013
Hooman Kamel
Few patients receive intravenous tissue plasminogen activator (TPA) within the optimal period of 90 minutes after stroke. Most efforts to speed
NEJM Journal Watch | 2012
Hooman Kamel
Widespread use of brain imaging has led to frequent identification of unruptured intracranial aneurysms. The patients and clinicians face a difficult
NEJM Journal Watch | 2012
Hooman Kamel
Traumatic brain injury (TBI) often causes disorders of consciousness such as minimally conscious or vegetative states. Psychotropic medications are
NEJM Journal Watch | 2012
Hooman Kamel
Tissue plasminogen activator (TPA) is an imperfect therapy for acute ischemic stroke, because it often fails to recanalize blocked vessels or prevent reocclusion after initial recanalization. Observational data suggest that patients already on antiplatelet therapy may have more recanalization and better outcomes after TPA, but current guidelines recommend withholding aspirin for 24 hours after TPA administration. To better assess the effect of …